Related Experiment Video

Updated: Jun 13, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Novel somatic mutations in heterotrimeric G proteins in melanoma

L Isabel Cárdenas-Navia1, Pedro Cruz, Jimmy C Lin

  • 1Cancer Genetics Branch, National Institutes of Health (NIH); Bethesda, MD, USA.

Cancer Biology & Therapy
|April 29, 2010
PubMed

Insights

This study reveals that mutations in heterotrimeric G proteins are common in melanoma. Specific genes like GNG10 and GNAZ show high mutation rates, suggesting their role in melanoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Heterotrimeric guanine nucleotide-binding proteins (G proteins) are crucial signal mediators in cellular pathways.
  • Mutations in G proteins, like GNAQ in uveal melanoma, are implicated in cancer development.
  • The role of the broader G protein gene family in malignant melanoma remains largely unexplored.

Purpose of the Study:

  • To conduct a comprehensive mutational analysis of the 35 genes encoding heterotrimeric G protein subunits in melanoma.
  • To identify specific G protein genes frequently altered in melanoma samples.
  • To investigate the potential involvement of G protein mutations in melanoma progression.

Main Methods:

  • Comprehensive mutational analysis of 35 heterotrimeric G protein family genes.
  • Analysis performed on a panel of 80 melanoma samples.
  • Detection and characterization of somatic alterations, including non-synonymous mutations.

Main Results:

  • Somatic alterations in G protein subunits were identified in 17% of the analyzed melanoma samples.
  • Mutations were found to span across 7 different G protein genes.
  • GNG10 and GNAZ exhibited the highest rates of somatic, non-synonymous mutations, with no prior reports in melanoma.

Conclusions:

  • This is the first systematic investigation of heterotrimeric G proteins in melanoma.
  • Multiple G protein subunits are somatically altered in melanoma, suggesting their involvement in the disease.
  • The newly identified mutations in GNG10 and GNAZ may play a significant role in melanoma pathogenesis and progression.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...